Chinese firm develops antigen test kit to detect new SARS-COV-2 variant
China | News | 0 Comment | 07 Jan, 2021
As the world watches a concerning new strain of SARS-COV-2 first identified in the United Kingdom, one global biote...Read more
Huami expands healthcare ecosystem in the Chinese market
China | News | 0 Comment | 06 Jan, 2021
Huami Corp. on Jan 5, 2020 announced that it has entered into an agreement to acquired 29.99% of the outstanding shares ...Read more
Y-Biologics, 3D Medicines collaborate to develop novel cancer therapeutics for China
China | News | 0 Comment | 06 Jan, 2021
The South Korean biotech company Y-Biologics and the China-based biopharmaceutical company 3D Medicines have entere...Read more
Inovio adds Asian manufacturing resource to COVID-19 vaccine candidate
China | News | 0 Comment | 05 Jan, 2021
INOVIO, a US based biotechnology company focused on bringing to market precisely designed DNA medicines to treat and pro...Read more
ImmVira Group announces signing of Series C financing
China | News | 0 Comment | 04 Jan, 2021
ImmVira Group Company, a biotechnology platform dedicated to the development of oncolytic virus(OV) and vector type appr...Read more
Chinese firm initiates R&D of liquid nitrogen biological containers for vaccines storage
China | News | 0 Comment | 04 Jan, 2021
CIMC Enric Holdings has announced that its subsidiary Zhangjiagang CIMC Sanctum Cryogenic Equipment Co., Ltd recent...Read more
OUE Lippo Healthcare strengthens partnership with China Merchants Group
China | News | 0 Comment | 01 Jan, 2021
OUE Lippo Healthcare, based in Singapore, has announced that following the formation of the Joint Venture for ...Read more
DXY completes $500 M financing to enhance role in healthcare sector
China | News | 0 Comment | 31 Dec, 2020
DXY, a leading digital healthcare technology company in China, announced the completion of a $500 million fina...Read more
Urban China to have highest cases of NSCLC over next decade, predicts GlobalData
China | News | 0 Comment | 30 Dec, 2020
Urban China is expected to have the highest number of diagnosed incident cases of non-small cell lung cancer (NSCLC) amo...Read more
China makes new inclusions in national reimbursement drug list
China | News | 0 Comment | 28 Dec, 2020
BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines w...Read more
NovoNordisk’s Rybelsus could be a game-changer in Type 2 Diabetes
China | News | 0 Comment | 23 Dec, 2020
NovoNordisk’s decision to investigate its recently launched Type 2 Diabetes (T2D) drug Rybelsus (semaglutide) in a...Read more
Suntrap Life Technologies discovers natural anti-COVID-19 compound
China | News | 0 Comment | 23 Dec, 2020
As the new coronavirus began to spread globally, Suntrap Life Technologies Ltd established a special research team. The ...Read more
WuXi Biologics acquires drug substance facility from Bayer
China | News | 0 Comment | 24 Dec, 2020
WuXi Biologics, a global company with leading open-access biologics technology platforms, and Bayer, have announced an a...Read more
China Medical System MSCI-ESG rating upgraded to "AA"
China | News | 0 Comment | 22 Dec, 2020
On December 17, the largest index provider, Morgan Stanley Capital International (MSCI) updated a report on the ESG (Env...Read more
CUHK designs novel microrobotic diagnostic system for infectious pathogens
China | News | 0 Comment | 23 Dec, 2020
The Chinese University of Hong Kong (CUHK) has recently developed a fully automated, low cost and rapid microrobotic dia...Read more
Harbour BioMed licenses SARS-CoV-2 neutralizing Ab to AbbVie for COVID-19 treatment
China | News | 0 Comment | 22 Dec, 2020
China based Harbour BioMed and Utrecht University in the Netherlands have announced that they licensed to American firm ...Read more
Takeda sells select non-core assets to Chinese firm for $322 M
China | News | 0 Comment | 21 Dec, 2020
Takeda Pharmaceutical Company, headquartered in Japan, has announced that it has entered into an agreement to divest a p...Read more
Fosun Pharma inks agreement with BioNTech for COVID-19 vaccine supply in China
China | News | 0 Comment | 16 Dec, 2020
BioNTech and Shanghai Fosun Pharmaceutical (Group) Co, Ltd have announced an agreement to supply Mainland China with 100...Read more